Lawrence Watts
Investor Relations, Gil Martin Group
Replay available
Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) Q4 2022 earnings conference call, held 2023-03-22. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Talat Imran
Chief Executive Officer, Rani Therapeutics
Amir Hashim
Chief Scientific Officer, Rani Therapeutics
Spike Sanford
Chief Financial Officer, Rani Therapeutics
Brendan Foulkes
Analyst, Cancer
Annabelle Samimi
Analyst, CIFL
Ash Verma
Analyst, UBS
Bert Hazlett
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Rani Therapeutics Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:05.454 Hello, and welcome to Roni Therapeutics' fourth quarter and four-year 2022 00:00:05.454 -- 00:00:08.857 financial results and corporate update conference call. 00:00:08.857 -- 00:00:12.540 At this time, all participants are in a listen-only mode. 00:00:12.540 -- 00:00:17.264 Following management's prepared remarks, we will hold a Q&A session. 00:00:17.264 -- 00:00:22.328 To ensure that we have ample time to address everyone's questions during the Q&A session, 00:00:22.328 -- 00:00:27.822 we will ask for a limit of one question and one follow-up question per person. 00:00:27.822 -- 00:00:32.146 As a reminder, this call has been recorded today, Wednesday, March the 22nd, 2023. 00:00:32.146 -- 00:00:34.788 I would now 00:00:34.788 -- 00:00:38.431 like to turn the conference over to Lawrence Watts of Gil Martin Group. 00:00:38.431 -- 00:00:41.152 Please go ahead, sir. 00:00:44.076 -- 00:00:48.679 Thank you, operator. Joining us on the call today from Rani Therapeutics are Chief Executive 00:00:48.679 -- 00:00:53.503 Officer, Talat Imran, Chief Financial Officer, Spike Sanford, and Chief Scientific Officer, 00:00:53.503 -- 00:00:55.623 Amir Hashim. 00:00:55.623 -- 00:00:58.665 During this conference call, management will make forward-looking statements that are 00:00:58.665 -- 00:01:03.267 subject to risks, uncertainties, and assumptions, such as, but not limited to, those 00:01:03.267 -- 00:01:06.749 discussed in the risk factors section of the company's filings with the Securities and 00:01:06.749 -- 00:01:11.511 Exchange Commission, including its annual report on Form 10-K and quarterly reports on 00:01:11.511 -- 00:01:16.654 Form 10-Q, which identify the specific factors that may cause actual events or 00:01:16.654 -- 00:01:20.716 r...